Posts Tagged ‘cancer’
Partner With Your Provider to Fight Ovarian Cancer
Annette Bicher, MD, is board-certified in gynecologic oncology and obstetrics and gynecology. Dr. Bicher is a member of the American College of Obstetricians and Gynecologists, Felix Rutledge Society of Gynecology/Oncology, Society of Gynecologic Oncologists and the Society of Gynecologic Investigation. She serves as Director of Gynecologic Oncology at Inova Fairfax Hospital. To detect breast cancer…
Read MoreInova Announces Gift to Endow Sheridan Director, Molecular Tumor Board at Inova Schar Cancer Institute
Falls Church, VA —Inova today announced that it has received a $1 million gift from Win Sheridan, co-founder of APEX Systems, to endow the role of the Director of the Molecular Tumor Board at Inova Schar Cancer Institute. In recognition of Sheridan’s generous gift, this position will be renamed to be the Sheridan Director, Molecular…
Read MoreHow to Tell Your Child About Your Cancer Diagnosis
Practical Strategies for Tough Conversations By Amanda L. Thompson, PhD, and Shari Langer, PsyD Amanda Thompson, PhD, is the Chief of Pediatric Psychology and Director of Pediatric Programs for Life with Cancer, a program of the Inova Schar Cancer Institute. Shari Langer, PsyD, is a pediatric psychologist with Life with Cancer at the Inova L.J.…
Read MoreAwake Brain Tumor Surgery Gives Valeria Back Her Quality of Life
Valeria Diggs is used to having a sharp memory. In her career as a human resources specialist for the federal government, Valeria is known as the go-to person for HR-related questions and time-sensitive requests. But in September 2019, the job she was so good at suddenly became harder to do. “I couldn’t remember things as…
Read MoreDealing with the Stress of a Cancer Diagnosis in a COVID-19 World with Exercise
Kirstie L. Pomaranski, CPT, CES, CETI- CES, PN1 is a certified fitness and exercise trainer. For more than a decade she has trained clients individually and in small group settings from the ages of 3 to 93. Kirstie oversees the exercise programming for cancer patients and survivors at Life with Cancer. Navigating a cancer diagnosis…
Read MoreProton Therapy for Pediatric Patients
Cancer is a formidable diagnosis, but it is even more disconcerting when it affects a child. Radiation, a traditional therapy to treat the disease, can harm a child’s growing body, resulting in developmental delays, hormone deficiencies, and restricted bone growth. Many of the pediatric patients also experience a long-term side effect from this therapy, including…
Read MoreDirect-to-Consumer Genetic Testing for Inherited Cancer Risk
Morgan Turner, MS, CGC, is a Virginia-licensed and nationally board-certified, cancer-specialized genetic counselor at Inova Schar Cancer Institute. She joined Inova in June 2018. Many patients are surprised to learn that the majority of people who are diagnosed with a cancer do not have a genetic (or inherited) cause for their cancer. Indeed, it is…
Read MoreInova Schar Cancer Institute Radiation Oncology Achieves Four-Year Accreditation for Radiation Oncology Services from ASTRO’s APEx – Accreditation Program for Excellence®
Falls Church, VA – Inova is proud to announce that all five radiation oncology departments within the Inova Schar Cancer Institute (ISCI) have been reaccredited by the American Society for Radiation Oncology (ASTRO) for APEx – Accreditation Program for Excellence®. APEx is an accreditation program developed by ASTRO that validates a radiation oncology facility’s excellence…
Read MoreHealthy Summer Nutrition Tips
Lauren Fay, RD, CSO, CNSC, is a registered dietitian at the Inova Schar Cancer Institute and Life With Cancer. She is board-certified in oncology nutrition and nutrition support. Summer is well underway, and with the warmer temperatures (and the ability to spend time in larger groups of our vaccinated family and friends) many of us…
Read MoreEarly Study Finds MGC018 Active in Resistant Skin Cancer
Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…
Read More